Pathogenesis and pathophysiology of heart failure with reduced ejection fraction: translation to human studies

Zijun Ge, Amy Li, James McNamara, Cris dos Remedios, Sean Lal

Research output: Contribution to journalReview articlepeer-review

12 Citations (Scopus)


Heart failure represents the end result of different pathophysiologic processes, which culminate in functional impairment. Regardless of its aetiology, the presentation of heart failure usually involves symptoms of pump failure and congestion, which forms the basis for clinical diagnosis. Pathophysiologic descriptions of heart failure with reduced ejection fraction (HFrEF) are being established. Most commonly, HFrEF is centred on a reactive model where a significant initial insult leads to reduced cardiac output, further triggering a cascade of maladaptive processes. Predisposing factors include myocardial injury of any cause, chronically abnormal loading due to hypertension, valvular disease, or tachyarrhythmias. The pathophysiologic processes behind remodelling in heart failure are complex and reflect systemic neurohormonal activation, peripheral vascular effects and localised changes affecting the cardiac substrate. These abnormalities have been the subject of intense research. Much of the translational successes in HFrEF have come from targeting neurohormonal responses to reduced cardiac output, with blockade of the renin-angiotensin-aldosterone system (RAAS) and beta-adrenergic blockade being particularly fruitful. However, mortality and morbidity associated with heart failure remains high. Although systemic neurohormonal blockade slows disease progression, localised ventricular remodelling still adversely affects contractile function. Novel therapy targeted at improving cardiac contractile mechanics in HFrEF hold the promise of alleviating heart failure at its source, yet so far none has found success. Nevertheless, there are increasing calls for a proximal, ‘cardiocentric’ approach to therapy. In this review, we examine HFrEF therapy aimed at improving cardiac function with a focus on recent trials and emerging targets.

Original languageEnglish
Pages (from-to)743-758
Number of pages16
JournalHeart Failure Reviews
Issue number5
Publication statusPublished - 15 Sep 2019
Externally publishedYes


  • Basic sciences
  • Heart failure
  • Human
  • Translational


Dive into the research topics of 'Pathogenesis and pathophysiology of heart failure with reduced ejection fraction: translation to human studies'. Together they form a unique fingerprint.

Cite this